1. Home
  2. HIT vs ANVS Comparison

HIT vs ANVS Comparison

Compare HIT & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Health In Tech Inc.

HIT

Health In Tech Inc.

HOLD

Current Price

$0.86

Market Cap

74.1M

Sector

Finance

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$1.31

Market Cap

76.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIT
ANVS
Founded
1964
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
76.6M
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
HIT
ANVS
Price
$0.86
$1.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$3.25
★ $13.50
AVG Volume (30 Days)
46.6K
★ 1.3M
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 100.00
39.39
EPS
★ N/A
N/A
Revenue
★ $33,327,511.00
N/A
Revenue This Year
$41.00
N/A
Revenue Next Year
$69.63
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 70.99
N/A
52 Week Low
$0.77
$1.04
52 Week High
$4.01
$5.50

Technical Indicators

Market Signals
Indicator
HIT
ANVS
Relative Strength Index (RSI) 39.92 43.69
Support Level $0.77 $1.04
Resistance Level $1.16 $2.43
Average True Range (ATR) 0.07 0.09
MACD 0.00 0.03
Stochastic Oscillator 40.09 76.79

Price Performance

Historical Comparison
HIT
ANVS

About HIT Health In Tech Inc.

Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: